Cadd M et al., 2024-10-05: Systematic review and meta-analysis comparing hydroxocobalamin with methylene blue in post-cardiac-surgery vasoplegia (four retrospective studies, 263 patients): no difference in vasopressor requirement at one hour.
There was no significant difference in the primary outcome, vasopressor requirement at 1 hour (mean difference [MD]: 0.00 mcg/kg/min norepinephrine equivalent [NEE], 95% confidence interval [CI]: -0.09 to 0.08).
Cadd M et al., 2024-10-05: Systematic review and meta-analysis comparing hydroxocobalamin with methylene blue in post-cardiac-surgery vasoplegia (four retrospective studies, 263 patients): no difference in vasopressor requirement at one hour. C5 (comparative). Study type: systematic review and meta-analysis of retrospective observational studies, 4 studies, N=263; Royal Sussex County Hospital, UK. Hydroxocobalamin was associated with a significant improvement in mean arterial pressure (per the abstract), so the comparison is not a clean win for methylene blue. Authors declare no competing interests. Comparator: hydroxocobalamin. J Cardiothorac Vasc Anesth 2024;38:3188-3199. Study type: review.
